Skip to content

The effect of Tabata training on physical fitness factors and sympathoadrenal and hypothalamus, pituitary, adrenal axes of normal and overweight girls

The effect of Tabata training on physical fitness factors and sympathoadrenal and hypothalamus, pituitary, adrenal axes of normal and overweight girls

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241229064200N1
Enrollment
40
Registered
2025-03-17
Start date
2024-11-21
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Changes in cortisol and salivary alpha-amylase levels during Tabata training..

Interventions

Intervention 1: Intervention group 1: Overweight - Tabata training, subjects performed Tabata training three times a week for 8 weeks. Tabata is an interval training method in which in a training sess

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 28 Years

Inclusion criteria

Inclusion criteria: Age 18 to 28 years. No history of cardiovascular or respiratory disease. Their weight gain was not related to hypothyroidism. No history of illness or any physical or orthopedic injury that would interfere with exercise. No participation in regular exercise activities in the past three months (and no history of exercise or calorie restriction). Subjects had not recently followed a special diet and had maintained a relatively stable weight for the past six months.

Exclusion criteria

Exclusion criteria: Presence of endocrine disorders or genetic syndromes; Use of other chronic cardiovascular diseases; medications that can affect growth, nutritional status, or diet. specific medications in the three months prior to the study: medications that affect heart rate, metabolism, and body weight, such as medications related to diabetes or thyroid diseases, antidepressants, anti-inflammatory, hormonal medications

Design outcomes

Primary

MeasureTime frame
Cortisol. Timepoint: Beginning of the study / End of the study (after eight weeks of Tabata training). Method of measurement: Salivary cortisol kit.;Alpha-amylase. Timepoint: Beginning of the study / End of the study (after eight weeks of Tabata training). Method of measurement: Saliva Alpha Amylase Kit.

Secondary

MeasureTime frame
Cortisol. Timepoint: The beginning of the study and the end of the study (after eight weeks of Tabata training). Method of measurement: Salivary cortisol kit.;Alpha amylase. Timepoint: The beginning of the study and the end of the study (after eight weeks of Tabata training). Method of measurement: Salivary Alpha Amylase Kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Mirzashaeri

Islamic Azad University

zahra.mirzashaeri@iau.ac.ir+98 21 4486 5154

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026